APA aipamena

Eliaçık, E., Işık, A., Aksu, S., Üner, A., Büyükaşık, Y., Sayınalp, N., . . . Haznedaroğlu, İ. C. (2015). Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms. Turk J Haematol.

Chicago Style aipamena

Eliaçık, Eylem, Ayşe Işık, Salih Aksu, Ayşegül Üner, Yahya Büyükaşık, Nilgün Sayınalp, Hakan Göker, Osman İ Özcebe, and İbrahim C. Haznedaroğlu. "Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms." Turk J Haematol 2015.

MLA aipamena

Eliaçık, Eylem, et al. "Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms." Turk J Haematol 2015.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.